These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14872332)

  • 1. Nephrogenic fibrosing dermopathy in pediatric patients.
    Jain SM; Wesson S; Hassanein A; Canova E; Hoy M; Fennell RS; Dharnidharka VR
    Pediatr Nephrol; 2004 Apr; 19(4):467-70. PubMed ID: 14872332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenic fibrosing dermopathy.
    Firoz BF; Hunzeker CM; Soldano AC; Franks AG
    Dermatol Online J; 2008 May; 14(5):11. PubMed ID: 18627747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
    Kim RH; Ma L; Hayat SQ; Ahmed MM
    J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients.
    Marco MP; Muray S; Betriu A; Craver L; Belart M; Fernández E
    Nephron; 2002 Oct; 92(2):499-500. PubMed ID: 12218343
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure.
    Swartz RD; Crofford LJ; Phan SH; Ike RW; Su LD
    Am J Med; 2003 May; 114(7):563-72. PubMed ID: 12753880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin thickening in a hemodialysis patient: a case of nephrogenic fibrosing dermopathy.
    Al Habeeb A; Partington S; Rosenthal D; Salama S
    J Cutan Med Surg; 2009; 13(2):110-4. PubMed ID: 19298781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.
    Jiménez SA; Artlett CM; Sandorfi N; Derk C; Latinis K; Sawaya H; Haddad R; Shanahan JC
    Arthritis Rheum; 2004 Aug; 50(8):2660-6. PubMed ID: 15334482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunity and cost of sevelamer in dialysis patients.
    Abderrhamane G; Renato D; Patrick F
    Kidney Int; 2005 Apr; 67(4):1636. PubMed ID: 15780128
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrogenic fibrosing dermopathy: a series in a non-Western population.
    Panda S; Bandyopadhyay D; Tarafder A
    J Am Acad Dermatol; 2006 Jan; 54(1):155-9. PubMed ID: 16384776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with sevelamer in peritoneal dialysis].
    Ortiz A; Ríos F; Melero R; Reyero A; Gazapo R; Casado S
    Nefrologia; 2003; 23(5):432-6. PubMed ID: 14658169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic fibrosing dermopathy with systemic involvement.
    Ting WW; Stone MS; Madison KC; Kurtz K
    Arch Dermatol; 2003 Jul; 139(7):903-6. PubMed ID: 12873886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic fibrosing dermopathy: two pediatric cases.
    Jan F; Segal JM; Dyer J; LeBoit P; Siegfried E; Frieden IJ
    J Pediatr; 2003 Nov; 143(5):678-81. PubMed ID: 14615747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
    Ogata H; Koiwa F; Shishido K; Kinugasa E
    Ther Apher Dial; 2005 Feb; 9(1):11-5. PubMed ID: 15828900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nephrogenic fibrosing dermopathy].
    Brisch M; Schneider T; Requena L; Mentzel T; Kutzner H
    J Dtsch Dermatol Ges; 2003 Jun; 1(6):464-7. PubMed ID: 16295140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis.
    Läuchli S; Zortea-Caflisch C; Nestle FO; Burg G; Kempf W
    Dermatology; 2004; 208(3):278-80. PubMed ID: 15118390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic fibrosing dermopathy: the first 6 years.
    Cowper SE
    Curr Opin Rheumatol; 2003 Nov; 15(6):785-90. PubMed ID: 14569211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.
    Mendoza FA; Artlett CM; Sandorfi N; Latinis K; Piera-Velazquez S; Jimenez SA
    Semin Arthritis Rheum; 2006 Feb; 35(4):238-49. PubMed ID: 16461069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sevelamer.
    Henderson J; Altmann P
    Nephron Clin Pract; 2003; 94(3):c53-8. PubMed ID: 12902631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic fibrosing dermopathy in two patients with systemic lupus erythematosus.
    Obermoser G; Emberger M; Wieser M; Zelger B
    Lupus; 2004; 13(8):609-12. PubMed ID: 15462493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic fibrosing dermopathy.
    Gambichler T; Paech V; Kreuter A; Wilmert M; Altmeyer P; Stücker M
    Clin Exp Dermatol; 2004 May; 29(3):258-60. PubMed ID: 15115505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.